{"id":"https://genegraph.clinicalgenome.org/r/e8fa981c-4e5e-4c24-96e0-d461b3d08d55v1.4","type":"EvidenceStrengthAssertion","dc:description":"*CUL4B* was first reported in relation to X-linked intellectual disability, Cabezas type in 2007 (Tarpey et al., PMID: 17236139). The reported phenotypes in affected males include intellectual disability, hypogonadism, delayed puberty, short stature, relative macrocephaly, central obesity, dysmorphic features, aggressive outbursts, tremor, seizures, and variable cerebral malformations (PMIDs: 17236139, 25385192). Carrier females have skewed X-chromosome inactivation and are unaffected.\n\nSix variants (splice, nonsense, frameshift) that have been reported in seven probands in three publications (PMIDs: 17236139, 17273978, 24898194) are included in this curation. Variants in this gene segregated with disease in additional family members. More evidence is available in the literature, but the maximum score for genetic evidence (12 points) has been reached. The mechanism of pathogenicity is reported to be loss of function. This gene-disease relationship is also supported by a mouse model (PMID: 22763239). CUL4B is a member of the cullin family of proteins that function as scaffold proteins for multiple ubiquitin-protein ligase complexes that regulate the degradation of target proteins.\n\nIn summary, there is definitive evidence supporting the relationship between *CUL4B* and X-linked intellectual disability, Cabezas type. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on February 21, 2018 (SOP Version 5). As of October 2025, this record underwent administrative updates to include an evidence summary text and update scoring to be consistent with SOP Version 11. No new evidence has been added.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/e8fa981c-4e5e-4c24-96e0-d461b3d08d55","GCISnapshot":"https://genegraph.clinicalgenome.org/r/cc93f3b2-3124-40f8-a86e-c929b09c6f68","calculatedEvidenceStrength":"Definitive","changes":[{"id":"cg:otherTextChange"},{"id":"cg:newEvidence"},{"id":"cg:sopChange"},{"id":"cg:summaryChange"}],"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/cc93f3b2-3124-40f8-a86e-c929b09c6f68_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2018-02-21T11:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/cc93f3b2-3124-40f8-a86e-c929b09c6f68_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2025-10-07T14:43:30.609Z","role":"Publisher"}],"curationReasons":["ErrorClarification"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cc93f3b2-3124-40f8-a86e-c929b09c6f68_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fe6ce4d3-39b6-4003-83a2-125676998012","type":"EvidenceLine","dc:description":"Recurrent variant, reported in an unrelated family (family 307) by Tarpey et al. (2007, PMID: 17236139)","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fe6ce4d3-39b6-4003-83a2-125676998012_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17273978","allele":{"id":"https://genegraph.clinicalgenome.org/r/15ac5de3-90bf-4a47-97e5-9184ef6812a3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001079872.2(CUL4B):c.1108C>T (p.Arg370Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/11339"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}},{"id":"https://genegraph.clinicalgenome.org/r/fe6ce4d3-39b6-4003-83a2-125676998012_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"CUL4B mRNA levels in leukocytes from 5 patients was reduced by 70%","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/ab7af417-747a-45b5-8254-c51386c77dd9","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ab7af417-747a-45b5-8254-c51386c77dd9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17236139","allele":{"id":"https://genegraph.clinicalgenome.org/r/d689fd6f-d52e-4bdc-9b46-60865493201b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001079872.2(CUL4B):c.953_957del (p.Ile318LysfsTer2)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/426723"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/cc93f3b2-3124-40f8-a86e-c929b09c6f68_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5af8dffc-30a2-49cc-8278-fc57464df698_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17236139","rdfs:label":"307","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/5af8dffc-30a2-49cc-8278-fc57464df698","type":"Family","rdfs:label":"307","member":{"id":"https://genegraph.clinicalgenome.org/r/e7bc4e06-ecbe-4d2e-8223-86b0b24627ba","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17236139","rdfs:label":"Proband 1 from Family 307","allele":{"id":"https://genegraph.clinicalgenome.org/r/15ac5de3-90bf-4a47-97e5-9184ef6812a3"},"detectionMethod":"Sequencing of 676 Vega-annotated genes on the X chromosome","firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0000750","obo:HP_0001249"],"previousTesting":true,"previousTestingDescription":"Normal karyotype and fragile X testing, negative screen of 61 known XL-ID genes","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/1371e6f2-738d-4052-8ba0-e7628e62094c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17236139","allele":{"id":"https://genegraph.clinicalgenome.org/r/15ac5de3-90bf-4a47-97e5-9184ef6812a3"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0001249","obo:HP_0000750"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/e7bc4e06-ecbe-4d2e-8223-86b0b24627ba"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/7b1f8f63-eeb3-4604-accc-bd7e80d7aa03_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24898194","rdfs:label":"Londin Family 1","family":{"id":"https://genegraph.clinicalgenome.org/r/7b1f8f63-eeb3-4604-accc-bd7e80d7aa03","type":"Family","rdfs:label":"Londin Family 1","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/40d4160e-4037-4633-8095-a50748ed9194","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24898194","rdfs:label":"Londin Proband 1 from Family 1","allele":{"id":"https://genegraph.clinicalgenome.org/r/6c422f46-90d9-4bd3-b388-c76a04c6a01b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001079872.2(CUL4B):c.920+1G>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA414199728"}},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000252","obo:HP_0001156","obo:HP_0001344","obo:HP_0001999","obo:HP_0001249","obo:HP_0004322"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/7f5aa0a6-8afd-421a-96cc-40e6900aa68c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24898194","allele":{"id":"https://genegraph.clinicalgenome.org/r/6c422f46-90d9-4bd3-b388-c76a04c6a01b"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":8,"phenotypes":["obo:HP_0004322","obo:HP_0001249","obo:HP_0000252","obo:HP_0001156","obo:HP_0001344","obo:HP_0001999"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/40d4160e-4037-4633-8095-a50748ed9194"},"publishedLodScore":3.61,"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/e16bd190-60f7-4e8c-b0a7-4314628a505a_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17236139","rdfs:label":"43","estimatedLodScore":3.31,"family":{"id":"https://genegraph.clinicalgenome.org/r/e16bd190-60f7-4e8c-b0a7-4314628a505a","type":"Family","rdfs:label":"43","member":{"id":"https://genegraph.clinicalgenome.org/r/a63599d4-8f0d-491e-b15b-7be602b64b12","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17236139","rdfs:label":"Proband 1 from Family 43","allele":{"id":"https://genegraph.clinicalgenome.org/r/a244a198-4579-48b1-bfcb-2590c7d9db92","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001079872.2(CUL4B):c.2512C>T (p.Arg838Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA414192940"}},"detectionMethod":"Sequencing of 676 Vega-annotated genes on the X chromosome","firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0001249","obo:HP_0000750"],"previousTesting":true,"previousTestingDescription":"Normal karyotype and fragile X testing, negative screen of 61 known XL-ID genes","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/98459872-a97e-4554-89eb-ba941276e206_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17236139","allele":{"id":"https://genegraph.clinicalgenome.org/r/a244a198-4579-48b1-bfcb-2590c7d9db92"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":8,"phenotypes":["obo:HP_0000750","obo:HP_0001249"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/a63599d4-8f0d-491e-b15b-7be602b64b12"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/bbc1bd8d-2cc7-48df-b0f7-cca35b73c9a1_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17236139","rdfs:label":"42","estimatedLodScore":0.9,"family":{"id":"https://genegraph.clinicalgenome.org/r/bbc1bd8d-2cc7-48df-b0f7-cca35b73c9a1","type":"Family","rdfs:label":"42","member":{"id":"https://genegraph.clinicalgenome.org/r/1d9a843d-4452-438f-9650-e89874e6320e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17236139","rdfs:label":"Proband 1 from Family 42","allele":{"id":"https://genegraph.clinicalgenome.org/r/d689fd6f-d52e-4bdc-9b46-60865493201b"},"detectionMethod":"Sequencing of 676 Vega-annotated genes on the X chromosome","firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0000750","obo:HP_0001249"],"previousTesting":true,"previousTestingDescription":"Normal karyotype and fragile X testing, negative screen of 61 known XL-ID genes","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/ab7af417-747a-45b5-8254-c51386c77dd9_variant_evidence_item"}}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0001249","obo:HP_0000750"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/1d9a843d-4452-438f-9650-e89874e6320e"}},{"id":"https://genegraph.clinicalgenome.org/r/50d20338-5add-44d0-a473-22034ed11191_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17236139","rdfs:label":"363","estimatedLodScore":0.9,"family":{"id":"https://genegraph.clinicalgenome.org/r/50d20338-5add-44d0-a473-22034ed11191","type":"Family","rdfs:label":"363","member":{"id":"https://genegraph.clinicalgenome.org/r/e6186764-56f8-4cd2-8382-590516563313","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17236139","rdfs:label":"Proband 1 from Family 363","allele":{"id":"https://genegraph.clinicalgenome.org/r/307f9100-f22b-47e0-83ce-327eaceab32d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001079872.2(CUL4B):c.2439G>A (p.Thr813=)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA518223541"}},"detectionMethod":"Sequencing of 676 Vega-annotated genes on the X chromosome","firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0001249","obo:HP_0000750"],"previousTesting":true,"previousTestingDescription":"Normal karyotype and fragile X testing, negative screen of 61 known XL-ID genes","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/20ea25f9-150a-4f8a-bb00-9a1993e5c15f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17236139","allele":{"id":"https://genegraph.clinicalgenome.org/r/307f9100-f22b-47e0-83ce-327eaceab32d"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0001249","obo:HP_0000750"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/e6186764-56f8-4cd2-8382-590516563313"}},{"id":"https://genegraph.clinicalgenome.org/r/5c6b81a4-ca28-4243-b27d-ee21c91f9063_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17273978","rdfs:label":"Zou Family 1","estimatedLodScore":3.61,"family":{"id":"https://genegraph.clinicalgenome.org/r/5c6b81a4-ca28-4243-b27d-ee21c91f9063","type":"Family","rdfs:label":"Zou Family 1","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/074029ca-12db-4e7b-a3d5-fd7fda154a91","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17273978","rdfs:label":"Zou Proband 1 from Family 1","allele":{"id":"https://genegraph.clinicalgenome.org/r/15ac5de3-90bf-4a47-97e5-9184ef6812a3"},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0004322","obo:HP_0000708","obo:HP_0001249","obo:HP_0000750"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/fe6ce4d3-39b6-4003-83a2-125676998012_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":7,"phenotypes":["obo:HP_0001249","obo:HP_0004322","obo:HP_0000708","obo:HP_0000750"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/074029ca-12db-4e7b-a3d5-fd7fda154a91"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/35dd54d8-f99d-4792-a818-c6e1deb92e45_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17236139","rdfs:label":"329","estimatedLodScore":0.9,"family":{"id":"https://genegraph.clinicalgenome.org/r/35dd54d8-f99d-4792-a818-c6e1deb92e45","type":"Family","rdfs:label":"329","member":{"id":"https://genegraph.clinicalgenome.org/r/59ea8976-66dd-4f05-b5dd-ec8336efc756","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17236139","rdfs:label":"Proband 1 from Family 329","allele":{"id":"https://genegraph.clinicalgenome.org/r/b744fe6a-5d37-4489-a94f-d3240c1f2be3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001079872.2(CUL4B):c.847-2A>G","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/11340"}},"detectionMethod":"Sequencing of 676 Vega-annotated genes on the X chromosome","firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0000750","obo:HP_0001249"],"previousTesting":true,"previousTestingDescription":"Normal karyotype and fragile X testing, negative screen of 61 known XL-ID genes","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/566b5215-581c-4039-b0ca-f55e035ea959_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17236139","allele":{"id":"https://genegraph.clinicalgenome.org/r/b744fe6a-5d37-4489-a94f-d3240c1f2be3"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0000750","obo:HP_0001249"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/59ea8976-66dd-4f05-b5dd-ec8336efc756"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/98459872-a97e-4554-89eb-ba941276e206","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/98459872-a97e-4554-89eb-ba941276e206_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/566b5215-581c-4039-b0ca-f55e035ea959","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/566b5215-581c-4039-b0ca-f55e035ea959_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/566b5215-581c-4039-b0ca-f55e035ea959_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Analysis of patient lymphocyte cDNA showed that the variant results in aberrant splicing of the CUL4B transcript, with exclusion of exon 7 and introduction of a frameshift.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/20ea25f9-150a-4f8a-bb00-9a1993e5c15f","type":"EvidenceLine","dc:description":"Score upgraded because this apparently silent variant results in aberrant splicing leading to premature truncation","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/20ea25f9-150a-4f8a-bb00-9a1993e5c15f_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/20ea25f9-150a-4f8a-bb00-9a1993e5c15f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Analysis of patient lymphocyte cDNA showed that this apparently silent variant results in aberrant splicing of the CUL4B transcript. The splice-donor site of intron 20 is ignored, and two new cryptic splice-donor sites are activated, resulting in exclusion of the end of exon 20 and introduction of a premature termination codon.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/1371e6f2-738d-4052-8ba0-e7628e62094c","type":"EvidenceLine","dc:description":"Recurrent variant, reported in a Chinese family by Zou et al. (2007, PMID: 17273978)","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1371e6f2-738d-4052-8ba0-e7628e62094c_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/1371e6f2-738d-4052-8ba0-e7628e62094c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Zou et al. (2007, PMID: 17273978) analyzed CUL4B mRNA levels in leukocytes from 5 patients in a Chinese family with the same variant and found a 70% reduction.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/7f5aa0a6-8afd-421a-96cc-40e6900aa68c","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7f5aa0a6-8afd-421a-96cc-40e6900aa68c_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/cc93f3b2-3124-40f8-a86e-c929b09c6f68_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cc93f3b2-3124-40f8-a86e-c929b09c6f68_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/772ae37a-0483-420f-97ad-21d0299362c4","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0f00bf4f-4106-41e8-b763-5f2fb5b6967b","type":"Finding","dc:description":"Because Cul4b-deficient mice die in utero, a conditional mouse model was created. Mice carrying conditional Cul4b-floxed alleles were crossed with Sox2-Cre transgenic mice, yielding offspring with deletion of Cul4b from E6.5, when Cre is expressed under the control of the Sox2 promoter. These Cul4b-deficient mice (Cul4b(Δ)/Y) showed impaired spatial learning and memory in the Morris water maze, but had normal performance in the passive avoidance test and the novel object recognition task. Cul4b(Δ)/Y mice also exhibited increased susceptibility to seizures. The number of parvalbumin-positive GABAergic interneurons was decreased in the hippocampus of Cul4b(Δ)/Y mice. These mice also exhibited reduced dendritic complexity and increased spine density in hippocampal neurons. Decreased inhibitory regulation and dendritic abnormalities may contribute to increased epileptic susceptibility and spatial learning deficits.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22763239","rdfs:label":"Conditional Cul4b knock-out mouse model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2}],"evidenceStrength":"Definitive","sequence":11947,"specifiedBy":"GeneValidityCriteria11","strengthScore":14,"subject":{"id":"https://genegraph.clinicalgenome.org/r/6-Hv1IVdsbc","type":"GeneValidityProposition","disease":"obo:MONDO_0010306","gene":"hgnc:2555","modeOfInheritance":"obo:HP_0001417"},"version":"1.4","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_cc93f3b2-3124-40f8-a86e-c929b09c6f68-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}